Investigating the Relationship Between Parents and Their Children With ADHD and Conduct Disorder
Tracking Information | |||
---|---|---|---|
First Submitted Date ICMJE | September 22, 2018 | ||
First Posted Date ICMJE | October 1, 2018 | ||
Last Update Posted Date | October 1, 2018 | ||
Actual Study Start Date ICMJE | October 1, 2018 | ||
Estimated Primary Completion Date | March 31, 2019 (Final data collection date for primary outcome measure) | ||
Current Primary Outcome Measures ICMJE |
Parental style and interactions with children[ Time Frame: 1 year ] Qualitative interview based on a phenomenological analysis will seek to understand from parents before, during, and after the treatment (previous intervention) about their interactions with their children, especially when problematic behavioural issues occur. All interviews were transcribed verbatim as much as possible, then subjected to a first round of open coding through identification of words, sentences or paragraphs expressing common ideas. Thereafter, a framework of themes was derived and interview content was organized systematically for analysis. The transcripts will also be rotated among researchers for the various stages of coding, such that each transcript was coded by at least two different people. This was to minimize subjectivity in coding and ensure the inter-rater consistency of the codes. |
||
Original Primary Outcome Measures ICMJE | Same as current | ||
Current Secondary Outcome Measures ICMJE |
|
||
Descriptive Information | |||
Brief Title ICMJE | Investigating the Relationship Between Parents and Their Children With ADHD and Conduct Disorder |
||
Official Title ICMJE | Investigating the Relationship Between Children With ADHD and Conduct Disorder and Their Parents in Reduction of Symptoms |
||
Brief Summary | This study aims to uncover mechanisms of action underlying any long-term change in youth antisocial behavior by considering the role of child and family characteristics as mediators and moderators of change. The study design is qualitative interviews to be conducted face-to-face with parents of children previously diagnosed with Conduct Disorder and Attention Deficit Hyperactivity Disorder (ADHD) but no longer meet diagnostic criteria. Questions will be asked to understand participants' parenting experience over time (before, during and after their children's treatment). |
||
Detailed Description | |||
Study Type ICMJE | Observational | ||
Study Phase | |||
Study Design ICMJE | Allocation: Intervention Model: Intervention Model Description: Masking: Observational Masking Description: Primary Purpose: |
||
Condition ICMJE | |||
Intervention ICMJE |
|
||
Study Arms |
|
||
Recruitment Information | |||
Recruitment Status ICMJE | Not yet recruiting | ||
Estimated Enrollment ICMJE |
20 | ||
Original Estimated Enrollment ICMJE | Same as current | ||
Estimated Study Completion Date | March 31, 2019 | ||
Estimated Primary Completion Date | March 31, 2019 (Final data collection date for primary outcome measure) | ||
Eligibility Criteria ICMJE | Inclusion Criteria: - Parents of children who participated in previous study "Supplements and Social Skills Intervention" conducted by Singapore Institute of Mental Health Child Guidance Clinic. - Children no longer meet the criteria for Conduct Disorder and ADHD, as measured by Antisocial Process Screening Device (APSD) Callous-Unemotional score of 7 or less, and who do not meet the cut-off for rule-breaking and aggressive behavior determined by Child Behavior Checklist (CBCL). These data were collected from a previous study. Exclusion Criteria: - Children who still meet the requirements of Conduct Disorder and ADHD as defined above. - Parents who did not indicate that they wish to be contacted for follow-up studies. | ||
Sex/Gender |
|
||
Ages | N/A and older (Adult, Older Adult) | ||
Accepts Healthy Volunteers | No | ||
Listed Location Countries ICMJE | |||
Removed Location Countries | |||
Administrative Information | Has Data Monitoring Committee | Yes | |
U.S. FDA-regulated Product |
Studies a U.S. FDA-regulated Drug Product: No Studies a U.S. FDA-regulated Device Product: No |
||
IPD Sharing Statement |
|
||
Responsible Party | , | ||
Study Sponsor ICMJE | Yale-NUS College | ||
Collaborators ICMJE | |||
Investigators ICMJE |
|
||
PRS Account | |||
Verification Date | September 2018 | ||
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |